Abstract A185: Phase I clinical, pharmacokinetic, and pharmacodynamic study of SB939, an oral histone deacetylase inhibitor (HDACi), in patients with advanced solid tumors Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Siu, Lillian L
  • Hotte, Sebastien
  • Chen, Eric X
  • Hirte, Holger
  • Powers, Jean
  • Stayner, Lee Anne
  • Iacobucci, Anne
  • Novotny‐Diermayr, Veronica
  • Zhu, Joy
  • Eisenhauer, Elizabeth A

publication date

  • December 10, 2009